Disclolist
A brokerage disclosure control that classifies artifacts under qualified policy, proposes approved labels, verifies rendered placement, and signs correctable receipts without claiming legal compliance.
The supplied research confirms that an Article 50 disclosure milestone arrived on August 2, 2026 and that a machine-readable marking milestone was deferred to December 2, 2026. As of this authoring, the August date has passed. The research found no real-estate-specific disclosure product. Disclolist inventories brokerage AI interactions and content surfaces, then applies a versioned policy approved by qualified counsel or compliance. It does not assume every AI-assisted listing, valuation, translation, message, or follow-up requires the same disclosure, and geolocation is only one uncertain input to applicability. The workflow separates artifact creation, applicability candidate, qualified decision, disclosure text and presentation, approval, delivery, destination readback, correction, and retention. A signed receipt proves integrity of the captured version and observations, not legal applicability, user comprehension, continuing display, or compliance.
The brokerage compliance, legal, marketing operations, digital product, or risk leader governing AI interactions and generated content across European-facing channels.
The August 2026 milestone has arrived and a December 2026 marking milestone remains in the supplied timeline.
Brokerage compliance and digital leaders have a concrete, dated governance problem across public and conversational surfaces.
The deadline and vertical workflow create the opening, while disclosure injection itself is a familiar control.
Confirmed 2026 milestones, a clear brokerage compliance buyer, multiple related ideas, and no vertical product found support a timely control layer.
No interfaces were verified, legal scope is artifact-specific, automatic location is unreliable, human policy review limits self-service economics, and incumbents can add disclosure controls.
Discussion
No comments yet — be the first to weigh in.
